Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
BPC-157 has primarily been associated in preclinical research with: Vascular support Fibroblast activity Collagen synthesis Soft tissue regeneration Thymosin Beta-4 has been investigated primarily for its role in: Cell migration Cytoskeletal organization Angiogenesis Cell differentiation Remodeling of damaged tissues The complementary nature of these mechanisms makes BPC-157 and Thymosin Beta-4 one of the most compelling peptide combinations currently being explored in regenerative research
Follow-up Repeat broad markers after 8-12 weeks if symptoms change or the protocol continues
Your body also needs energy to function and be productive when youre awake
Phase Tirz escalation 1 Weeks 5-8 Tirzepatide 5.0 mg/week Cagrilintide Not started Notes Continue tirzepatide alone
What we know about extended use The longest controlled human trials ran for 12 weeks
US$ 21.17
US$ 25.10
US$ 23.28
US$ 20.75
US$ 25.01
US$ 22.92
